Patents by Inventor Charles Harding Rhodes

Charles Harding Rhodes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120288544
    Abstract: The present invention relates to an oral dosage form comprising N-(2-amino-4-(fluorobenzylamino)-phenyl)carbamic acid ethyl ester (retigabine) or a pharmaceutically acceptable salt or solvate thereof, to a process for preparing such a dosage form and to the use of such a dosage form in medicine.
    Type: Application
    Filed: January 18, 2011
    Publication date: November 15, 2012
    Applicant: GLAXO GROUP LIMITED
    Inventors: Matthew Burke, Charles Harding Rhodes